RDZ-21519-37560 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-21
Dose 1 — Pfizer-BioNTech
2021-06-11
Dose 2 — Pfizer-BioNTech
2022-01-22
Dose 3 — Pfizer-BioNTech
2022-01-23
Registered in v-safe
2022-01-23
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2022-01-25
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-27
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-29
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-02-05
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2022-02-12
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-19
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-26
Survey response — day 35, dose 3
MedDRA: Decreased appetite, Disorientation, Dizziness, Fatigue, Peripheral coldness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Dizziness. Icy fingertips. Exhaustion. Disorientation. Loss of appetite.

MedDRA releases: 2024-11 · check-in free text available
2022-03-05
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-24
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-07-23
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-10-14
Dose 4 — Pfizer-BioNTech
2023-01-22
Survey response — 12 months, dose 3
MedDRA: COVID-19, Cough, Migraine, Nausea, Neuralgia, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-22
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-23
Call 1 — Left Voicemail
2023-01-23
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-21	Pfizer-BioNTech	No
2	2021-06-11	Pfizer-BioNTech	No
3	2022-01-22	Pfizer-BioNTech	No
4	2022-10-14	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — day 35, dose 3

2022-02-26

Symptoms: Dizziness. Icy fingertips. Exhaustion. Disorientation. Loss of appetite.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Decreased appetite	·	·	✓
SD	Disorientation	·	·	✓
SD	Dizziness	·	·	✓
SD	Fatigue	·	·	✓
SD	Migraine	·	·	✓
SD	Nausea	·	·	✓
SD	Neuralgia	·	·	✓
SD	Pain	·	·	✓
SD	Peripheral coldness	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release